Condition

Myelodysplastic Syndrome Acute Myeloid Leukemia clinical trials and research

• 2Clinical trials
• 6Countries

All recruiting trials (2)

• Investigating APL-4098 with Azacitidine for treating relapsed or refractory AML and high-risk MDS

  This study is testing a new treatment called APL-4098, alone and with azacitidine, to see if it can help people with relapsed or hard-to-treat acute myeloid leukemia and high-risk myelodysplastic syndrome.

  Recruiting at 8 sites Phase 1 Apollo Therapeutics Ltd · Clayton, Victoria and 8 other locations · NCT06372717

• AB8939 treatment for patients with relapsed or refractory acute myeloid leukemia

  This study is testing a new treatment called AB8939 to see if it can help people with relapsed or hard-to-treat acute myeloid leukemia feel better and improve their condition.

  Recruiting at 8 sites Phase 1/2 AB Science · Houston, Texas and 9 other locations · NCT05211570

Related topics

Quick answers

How many Myelodysplastic Syndrome Acute Myeloid Leukemia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in Australia (1 trial), United Kingdom (1 trial), France (1 trial), Greece (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →